Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection

BACKGROUND: Chronic hepatitis C virus (HCV) infection with genotypes (GT) 1 and 2 accounts for over 50% of HCV infections globally, including over 97% of all HCV infections in Japan. Here, we report an integrated analysis of efficacy and safety of 8-week treatment with the all-oral, fixed-dose combi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Gastroenterol
Auteurs principaux: Naganuma, Atsushi, Chayama, Kazuaki, Notsumata, Kazuo, Gane, Edward, Foster, Graham R., Wyles, David, Kwo, Paul, Crown, Eric, Bhagat, Abhi, Mensa, Federico J., Otani, Tetsuya, Larsen, Lois, Burroughs, Margaret, Kumada, Hiromitsu
Format: Artigo
Langue:Inglês
Publié: Springer Japan 2019
Sujets:
Original Article—Liver, Pancreas, and Biliary Tract
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6647445/
https://ncbi.nlm.nih.gov/pubmed/30868245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-019-01569-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires